Despite the impact of post-stroke cognitive impairment on the patient, and the additional impact of multi-morbidity, there is a poor evidence base for making clinical decisions about treatment in this patient group.1 Indeed, more research is needed to understand the interaction of these symptoms, how best to treat them, and how treatment of post-stroke cognitive impairment may affect the treatment of other neurobehavioural consequences of stroke and vice versa.1
References:
1. El Husseini N, Katzan IL, Rost NS, et al.; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; and Council on Lifestyle and Cardiometabolic Health. Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association/American Stroke Association. Stroke 2023; 54 (6): e272–e291.
2. Lanctôt KL, Lindsay MP, Smith EE, et al.; Management of Mood, Cognition and Fatigue Following Stroke Best Practice Writing Group, the Heart & Stroke Canadian Stroke Best Practices and Quality Advisory Committee; in collaboration with the Canadian Stroke Consortium. Canadian stroke best practice recommendations: mood, cognition and fatigue following stroke, 6th edition update 2019. Int J Stroke 2020; 15 (6): 668–688.
3. van Dalen JW, Moll van Charante EP, Nederkoorn PJ, et al. Poststroke apathy. Stroke 2013; 44 (3): 851–860.